4576 · D.Western Therapeutics Institute, Inc. · Financials
Market Cap
2.94B JPY
Shares
57.59M
Volume · Nov 11
190.9K
Avg daily vol (3M)
346.37K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
387.62M
-17.8%
FY2025
Net Income
-632.09M
+51%
FY2025
Gross Margin
89.97%
-0.1pp
FY2025
Operating Margin
-159.92%
+96.6pp
FY2025
Operating Cash Flow
-493.79M
+62%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| JPY | 387.62M | 471.58M | 428.36M | 448.1M | 414.42M |
| JPY | 38.86M | 46.84M | 36.67M | 27.57M | 20.1M |
| JPY | 348.76M | 424.74M | 391.7M | 420.53M | 394.32M |
| JPY | -619.87M | -1.21B | -798.56M | -305.91M | -171.65M |
| JPY | -630.49M | -1.29B | -826.8M | -440.27M | -159.71M |
| JPY | 1.6M | 1.6M | 1.6M | 1.6M | 1.6M |
| JPY | -632.09M | -1.29B | -812.41M | -429.69M | -149M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.